Last reviewed · How we verify
Ketamine-Fentanyl
At a glance
| Generic name | Ketamine-Fentanyl |
|---|---|
| Also known as | Ketamine (Ketalar) Fentanyl (Fentanyl Citrate) |
| Sponsor | Sait Fatih Öner |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Experienced sedation beyond postanesthesia care unit
- Oxygen requirement beyond postanesthesia care unit
- Experienced vomiting
- Severe bradycardia
- Experienced pruritis
Key clinical trials
- Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine (PHASE3)
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Cardiac Index and General Anesthesia Without Opioid. (PHASE2, PHASE3)
- The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delivery Under Spinal Anesthesia (NA)
- Ketamine-lidocaine Versus Ketamine-fentanyl for Induction of Anesthesia in Patients With Left Ventricular Systolic Dysfunction Undergoing Elective Coronary Artery Bypass (NA)
- Prospective IR-led Sedation Feasibility (PHASE1, PHASE2)
- Prehospital Analgesia INtervention Trial (PAIN) (PHASE3)
- Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstructive Sleep Apnea (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |